These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11003027)

  • 1. Gene therapy with angiogenic factors for the treatment of ischemic diseases.
    Melillo G; Capogrossi MC
    Ital Heart J; 2000 Sep; 1 Suppl 3():S59-60. PubMed ID: 11003027
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
    Ylä-Herttuala S; Markkanen JE; Rissanen TT
    Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
    Losordo DW; Dimmeler S
    Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis in the human heart: gene and cell therapy.
    Tirziu D; Simons M
    Angiogenesis; 2005; 8(3):241-51. PubMed ID: 16308736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis. Devising new strategies based on past experiences.
    Lei Y; Haider HKh; Shujia J; Sim ES
    Basic Res Cardiol; 2004 Mar; 99(2):121-32. PubMed ID: 14963670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic angiogenesis: translating experimental concepts to medically relevant goals.
    Emanueli C; Madeddu P
    Vascul Pharmacol; 2006 Nov; 45(5):334-9. PubMed ID: 17008132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for therapeutic angiogenesis and myogenesis in patients with advanced coronary disease.
    Ellis SG; Cura FA; Mukherjee D
    J Invasive Cardiol; 1999 Oct; 11(10):615-7. PubMed ID: 10745443
    [No Abstract]   [Full Text] [Related]  

  • 11. A balancing act: therapeutic approaches for the modulation of angiogenesis.
    Springer ML
    Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation.
    van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH
    Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness of gene therapy with transforming growth factor-beta or extracorporal shock wave therapy to reduce ischemic necrosis in an epigastric skin flap model in rats.
    Huemer GM; Meirer R; Gurunluoglu R; Kamelger FS; Dunst KM; Wanner S; Piza-Katzer H
    Wound Repair Regen; 2005; 13(3):262-8. PubMed ID: 15953045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic and antiangiogenic gene therapy.
    Malecki M; Kolsut P; Proczka R
    Gene Ther; 2005 Oct; 12 Suppl 1():S159-69. PubMed ID: 16231050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization.
    Tateno K; Minamino T; Toko H; Akazawa H; Shimizu N; Takeda S; Kunieda T; Miyauchi H; Oyama T; Matsuura K; Nishi J; Kobayashi Y; Nagai T; Kuwabara Y; Iwakura Y; Nomura F; Saito Y; Komuro I
    Circ Res; 2006 May; 98(9):1194-202. PubMed ID: 16574905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release systems of angiogenic growth factors for cardiovascular diseases.
    Esaki J; Marui A; Tabata Y; Komeda M
    Expert Opin Drug Deliv; 2007 Nov; 4(6):635-49. PubMed ID: 17970666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combating cardiovascular disease with angiogenic therapy.
    Jacobs J
    Drug Discov Today; 2007 Dec; 12(23-24):1040-5. PubMed ID: 18061883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic angiogenesis: another passing phase?
    Semenza GL
    Circ Res; 2006 May; 98(9):1115-6. PubMed ID: 16690890
    [No Abstract]   [Full Text] [Related]  

  • 20. Human FGF-1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters.
    Caron A; Michelet S; Caron A; Sordello S; Ivanov MA; Delaère P; Branellec D; Schwartz B; Emmanuel F
    J Gene Med; 2004 Sep; 6(9):1033-45. PubMed ID: 15352076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.